VEGFR has been found to be overexpressed in many cancer types such as melanoma, medulloblastoma and ovarian cancer.39 A reduction in VEGFR-2 results in a reduction in blood flow to tumor cells, thereby suppressing tumor angiogenesis.40 Here, KDR is linked to medulloblastoma.